Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Novo Nordisk Stock Slides After Roche Strikes Weight-Loss Deal
Novo Nordisk Stock Slides After Roche Strikes Weight-Loss Deal · The Wall Street Journal

In This Article:

Swiss pharmaceutical company Roche struck a multibillion-dollar collaboration and licensing deal with Zealand Pharma to co-develop a weight-loss treatment. Roche's stock rallied in Europe, while Zealand surged nearly 40%.